Clinical relevance of elevated serum thrombomodulin and soluble E- selectin in patients with Wegener's granulomatosis and other systemic vasculitides

American Journal of Medicine

Volumn 101, Issue 4, 1996, Pages 387-394

  Boehme, Michael W J ^a   Schmitt, Wilhelm H ^b   Youinou, Pierre ^c   Stremmel, Wolfgang R ^a   Gross, Wolfgang L ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; THROMBOMODULIN;

ADULT; AORTA ARCH SYNDROME; ARTICLE; BEHCET DISEASE; BLOOD LEVEL; BLOOD VESSEL INJURY; DISEASE ACTIVITY; DISEASE COURSE; ENDOTHELIUM INJURY; ENDOTHELIUM LESION; GIANT CELL ARTERITIS; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RELAPSE; VASCULITIS; WEGENER GRANULOMATOSIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BEHCET SYNDROME; C-REACTIVE PROTEIN; E-SELECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYARTERITIS NODOSA; RETROSPECTIVE STUDIES; TAKAYASU'S ARTERITIS; TEMPORAL ARTERITIS; THROMBOMODULIN; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0030271734     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00230-6     Document Type: Article

References (61)

1. 1. Pall AA, Savage COS. Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol. 1994;16:23-37.
2. 2. Fauci AS, Haines BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutical experience with 85 patients for 25 years. Ann Intern Med. 1983;98:76-85.
3. 3. Ballieux BEPB, Hiemstra PS, Klar-Mohamad N, et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol. 1994;24:3211-3215.
4. 4. Mayet WJ, Schwarting A, Meyer zum Büschenfelde KH. Cytotoxic effects of antibodies to proteinase 3 (c-ANCA) on human endothelial cells. Clin Exp Immunol. 1994;97:458-465.
5. 5. Nölle B, Specks U, Lüdemann J, et al. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Int Med. 1989;111:28-40.
6. 6. Jayne DRW, Jones SJ, Severn A, et al. Sever pulmonary hemorrhage and systemic vasculitis in association with circulation anti-neutrophil cytoplasm antibodies of IgM class only. Clin Nephrol. 1989;32:101-104.
7. 7. Cohen TJW, van der Woude FJ, Fauci AS, et al. Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med. 1989;149:2461-2465.
8. 8. Schmitt WH, Heesen C, Csernok E, et al. Elevated serum levels of soluble interleukin-2 receptor in patients with wegener's granulomatosis. Arthritis Rheum. 1992;35:1088-1096.
9. 9. Boehme MWJ, Nawroth PP, Kling E, et al. Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1994;37:572-577.
10. 10. Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalysed activation of protein C. Proc Natl Acad Sci USA. 1981;78:2249-2252.
11. 11. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem. 1982;257:859-864.
12. 12. Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 1990;75:329-336.
13. 13. Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987;235:1348-1352.
14. 14. Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985;76:2178-2181.
15. 15. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990;76:2024-2029.
16. 16. Ishii H, Nakano M, Tsubouchi J, et al. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thromb Haemost. 1990;63:157-162.
17. 17. Kodama S, Uchijima E, Nagai M, et al. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chim Acta. 1990;192:191-200.
18. 18. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991;65:618-623.
19. 19. Sawada K, Yamamoto H, Yago H, Suehiro S. A simple assay to detect 7 endothelial cell injury; measurement of released thrombomodulin from cells. Exp Mol Pathol. 1992;57:116-123.
20. 20. Takahashi H, Ito S, Hanano M, et al. Circulating thrombomodulin as a novel endothelial cell marker: Comparision of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol. 1992;41:32-39.
21. 21. Gearing AJH, Hemingway I, Pigott R, et al. Soluble forms of vascular adhesion molecules, E-Selectin, ICAM-1, and VCAM-1: pathological significance. Ann New York Acad Sci USA. 1992;667:324-331.
22. 22. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
23. 23. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood. 1994;84:2068-2101.
24. 24. Leavitt RY, Fauci AS, Bloch DA, et al. The american college of rheumatology 1990 criteria for the classification of wegener's granulomatosis. Arthritis Rheum. 1990;33:1101-1107.
25. 25. Arend WP, Michel BA, Bloch DA, et al. The american college of rheumatology 1990 criteria for the classification of takayasu arteritis. Arthritis Rheum. 1990;33:1129-1134.
26. 26. Hunder GG, Bloch DA, Michel BA, et al. The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
27. 27. Lightfoot RW, Michel BA, Bloch DA, et al. The american college of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088-1093.
28. 28. O'Duffy JD. Behcet's syndrome. N Engl J Med. 1990;322:326-328.
29. 29. Boehme MWJ, Werle E, Kommerell B, Raeth U. Serum levels of adhesion molecules and thrombomodulin as indicator of vascular injury in sever plasmodium falciparum malaria. Clin Invest. 1994;72:598-603.
30. 30. Hergesell O, Andrassy K, Geberth S, et al. Plasma thrombomodulin levels are dependent on renal function. Thromb Res. 1993;72:455-458.
31. 31. Carlos T, Kovach N, Schwartz B, et al. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 1991;77:2266-2271.
32. 32. Pigott R, Dillon LP, Hemingway IH, Gearing AJH. Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Com. 1992;187:584-589.
33. 33. Leeuwenberg JFM, Smeets EF, Neefjes JJ, et al. E-selectin and intercellular adhesion molecules-1 are released by activated human endothelial cells in vitro. Immunology. 1992;77:543-549.
34. 34. Carson CW, Beall LD, Hunder GG, et al. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol. 1993;20:809-814.
35. 35. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993;14:506-512.
36. 36. Newman W, Beall LD, Carson CW, et al. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol. 1993;150:644-654.
37. 37. Cronstein BN, Weissmann G. The adhesion molecules of inflammation. Arthritis Rheum. 1993;36:147-157.
38. 38. Mrowka C, Sieberth HG. Circulating adhesion molecules ICAM-1, VCAM-1, and E-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Invest. 1994;72: 762-768.
39. 39. Stegeman CA, Tervaert JW, Huitema MG, et al. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during followup. Arthritis Rheum. 1994;37:1228-1235.
40. 40. Spronk PE, Bootsma H, Huitema MG, et al. Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study. Clin Exp Immunol. 1994;97:439-444.
41. 41. Boehme MWJ, Nawroth PP, Kling E, et al. Levels of soluble serum thrombomodulin and adhesion molecules E-selectin and ICAM-1 as disease activity parameters in systemic lupus erythematosus. Clin Exp Rheumatol. 1994;12, Supp. S100.
42. 42. Moore KL, Esmon CT, Esmon NL. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 1989;73:159-165.
43. 43. Conway EM, Boffa M-C, Nowakowski B, Steiner-Mosonyi M. An ultrastructural study of thrombomodulin endocytosis: internalization occurs via clathrincoated and non-coated pits. J Cell Physiol. 1992;151:604-612.
44. 44. Brisson C, Archipoff G, Hartmann M-L, et al. Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb Haemost. 1992;68:737-743.
45. 45. Hirokawa K, Aoki N. Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol. 1991;147:157-165.
46. 46. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-α: comparison of transcriptional and posttranscriptional mechanisms. Blood. 1991;77:542-550.
47. 47. Abe H, Okajima K, Okabe H, et al. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med. 1994;123:874-881.
48. 48. Asakura H, Jokaji H, Saito M, et al. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol. 1991;38:281-287.
49. 49. Takahashi H, Hanano M, Wada K, et al. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol. 1991;38:174-177.
50. 50. Tanaka A, Ishii H, Hiraishi S, et al. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem. 1991;37:269-272.
51. 51. Takakuwa T, Endo S, Nakae H, et al. Plasma levels of TNF-alpha, endothelin-1 and thrombomodulin in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;84:261-269.
52. 52. Takaya M, Ichikawa Y, Kobayashi N, et al. Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol. 1991;9:495-499.
53. 2-plasmin inhibitior-plasmin complex are elevated in active systemic lupus erythematosus. J Rheumatol. 1992;19:1704-1709.
54. 54. Ohdama S, Matsubara O, Aoki N. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries. Chest. 1994;106:666-671.
55. 55. Himmelreich G, Riewald M, Rosch R, et al. Thrombomodulin. A marker for endothelial damage during orthotopic liver transplantation. Am J Hematol. 1994;47:1-5.
56. 56. Boehme MWJ, Deng Y, Raeth U, et al. Release of thrombomodulin from endothelial cells by concerted action of TNFα and neutrophils: in vivo and in vitro studies. Immunology. 1996; 87: 134-140.
57. 57. Mayet W-J, Csernock E, Szymkowiak C, et al. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomotosis. Blood. 1993;82:1221-1229.
58. 58. Gross WL, Schmitt HL, Csernock E. ANCA and associated diseases 1992. Immunodiagnostic and pathogenetic aspects. Clin Exp Immunol. 1993;91:1-12.
59. 59. Mayet W-J, Meyer zum Büschenfelde K-H. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin Exp Immunol. 1993;94:440-446.
60. 60. Mayet W-J, Schwarting A, Meyer zum Büschenfelde K-H. Cytotoxic effects of antibodies to proteinase 3 (c-ANCA) on human endothelial cells. Clin Exp Immunol. 1994;96:458-465.
61. 61. Ballieux BEPB, Hiemstra PS, Klar-Mohamad N, et al. Detachment and cytolysis of human endothelial cells by proteinase 3. Eur J Immunol. 1994;24:3211-3215.